Welcome to our dedicated page for Itron SEC filings (Ticker: ITRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From smart meters that log every kilowatt-hour to cloud analytics that predict water-line failures, Itron’s business spans hardware, software, and services—so its SEC disclosures can feel like a maze of technical terms and segment tables. If you have ever opened the Itron annual report 10-K simplified and wondered where the grid-edge revenue is buried, you are not alone.
Stock Titan solves that problem. Our AI reads each document the moment it hits EDGAR, turning hundreds of pages into clear answers. Need the latest Itron quarterly earnings report 10-Q filing? You will see an executive summary, key KPI trend charts, and side-by-side YOY segment comparisons. Curious about Itron insider trading Form 4 transactions? Real-time alerts flag every director buy or sell, so you can spot patterns before the market reacts.
- Track Itron Form 4 insider transactions real-time alongside price charts.
- Browse concise notes that make Itron 8-K material events explained in plain English.
- Drill into the Itron proxy statement executive compensation to see how pay aligns with smart-grid milestones.
Whether you are comparing backlog figures, monitoring R&D intensity, or looking for Itron executive stock transactions Form 4, our platform keeps every filing—and every insight—in one place. AI-powered summaries, keyword search across footnotes, and downloadable tables mean understanding Itron SEC documents with AI is finally practical. Save hours on manual review and focus on what matters: the numbers that drive Itron’s transformation of global utility infrastructure and the signals hidden inside each Itron earnings report filing analysis.
Form 144 notice for proposed sale of Itron, Inc. (ITRI) securities. The filer reports an intended sale of 565 common shares through Fidelity Brokerage Services with an aggregate market value of $70,798.51 and an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 by restricted stock vesting from the issuer and were received as compensation. The filing also discloses three prior sales by John Marcolini during May–June 2025 totaling 11,233 shares for gross proceeds of $1,328,377.61. The submission includes the required representation about public disclosure and trading-plan statements. Some standard filer/issuer identification fields are blank in the provided text.
Form 144 notice for proposed sale of 547 shares of common stock, to be effected through Fidelity Brokerage Services on NASDAQ on 08/25/2025 with an aggregate market value of $68,542.99. The filing shows these 547 shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and were recorded as compensation paid on 08/22/2025. The filing also discloses a prior sale by Donald Reeves of 529 shares on 05/27/2025 for gross proceeds of $60,805.96. The form lists total shares outstanding as 45,717,933. Several identifying fields for the filer and issuer (CIK, issuer name and contact details) are blank in the provided content.
Form 144 notice for Itron, Inc. (ITRI) shows a proposed sale of 1,786 common shares held at Fidelity Brokerage Services with an aggregate market value of $223,798.48, with an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 through restricted stock vesting and the payment nature is listed as compensation. The filing also discloses prior sales by the same person in the past three months: 1,729 shares sold on 05/27/2025 for $198,740.08 and 35,461 shares sold on 06/04/2025 for $4,245,142.69. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Itron Inc. (ITRI) Form 144 shows a proposed sale of 388 common shares through Fidelity Brokerage Services LLC on 08/25/2025 with an aggregate market value of $48,619.15. The shares were acquired on 08/22/2025 through restricted stock vesting from the issuer and were paid as compensation. The filing also discloses two prior sales by the same individual: 375 shares on 05/27/2025 for $43,104.41 and 9,036 shares on 06/10/2025 for $1,100,313.72. The filer certifies no undisclosed material adverse information.
Itron, Inc. (ITRI) received an initial Form 3 reporting that director Sheri Savage does not beneficially own any equity securities of the company as of the event date 08/11/2025. The filing was submitted by an attorney-in-fact on 08/18/2025. This Form 3 is an initial Section 16 disclosure required when an individual becomes a director; it documents current ownership (here, no securities) rather than any transaction or derivative position.
Laurie Ann Pulatie-Hahn, SVP, HR at Itron, Inc. (ITRI) sold 78 shares of Itron common stock on 08/11/2025 at a reported price of $124.6465 per share. The filing states the shares were automatically sold to satisfy tax-withholding obligations arising from the vesting of a restricted stock unit award, indicating this was a withholding sale rather than a discretionary market sale.
After the reported transaction, Ms. Pulatie-Hahn beneficially owns 22,219 shares of Itron common stock in a direct ownership form. The Form 4 shows the transaction code and clarifies the sale was tied to tax withholding for vested RSUs, with no other derivative or additional transactions reported.
Itron Inc (ITRI) Form 144 reports a proposed sale of 78 common shares through Fidelity Brokerage Services with an aggregate market value of $9,722.43. The filing lists 45,717,933 shares outstanding and indicates the proposed sale date as 08/11/2025 on NASDAQ. The shares were acquired on 08/08/2025 by restricted stock vesting from the issuer and were paid as compensation. The notice also discloses two prior sales by Laurie A. Hahn of 76 and 107 shares on 05/12/2025 and 05/27/2025, producing gross proceeds of $8,354.62 and $12,299.13. The signer represents no undisclosed material adverse information.
FAQ
What is the current stock price of Itron (ITRI)?
What is the market cap of Itron (ITRI)?
